← Leaderboards
Masaki Mizuno
Ut Southwestern Medical Center
$1,833,891
Attributed
$1,833,891
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $560.2K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$1,833,891 · 1
By mechanism
R01$1,833,891 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Philipp E Scherer$40,932,820
- Yong Xu$17,937,421
- Congcong He$7,200,039
- Chieko Mineo$9,253,798
- Abhimanyu Garg$28,553,253
Others in their field
Other Emerging Leaders on “Insulin Resistance”
- Barbara Halina Braffett · George Washington University$17,257,975
- Ionut Bebu · George Washington University$14,057,850
- Joshua Wiley Knowles · Stanford University$7,436,668
- Vaia Lida Chatzi · University Of Southern California$6,334,730
- Petter Bjornstad · University Of Colorado Denver$6,184,413
- Pankaj Arora · University Of Alabama At Birmingham$5,870,690
Research focus
Insulin ResistanceInsulin Signaling PathwayHyperinsulinismInsulinExerciseEvolutionExertionGenerationsImpairmentInnovationCardiovascular SystemBlood PressureAfferent NeuronsCharacteristicsChronicBrainClinical PracticeAnimalsCardiovascular AbnormalitiesDiabetes MellitusDiabeticCardiovascular DiseasesEventIn Vitro
Grant awards (7)
TARGETING INSULIN RESISTANCE TO IMPROVE ABNORMAL CARDIOVASCULAR CONTROL IN DIABETES$395,341
R01 · FY2023 · HL · contact PI
TARGETING INSULIN RESISTANCE TO IMPROVE ABNORMAL CARDIOVASCULAR CONTROL IN DIABETES$395,608
R01 · FY2022 · HL · contact PI
TARGETING INSULIN RESISTANCE TO IMPROVE ABNORMAL CARDIOVASCULAR CONTROL IN DIABETES$79,020
R01 · FY2022 · HL · contact PI
TARGETING INSULIN RESISTANCE TO IMPROVE ABNORMAL CARDIOVASCULAR CONTROL IN DIABETES$402,359
R01 · FY2021 · HL · contact PI
TARGETING INSULIN RESISTANCE TO IMPROVE ABNORMAL CARDIOVASCULAR CONTROL IN DIABETES$118,441
R01 · FY2021 · HL · contact PI
TARGETING INSULIN RESISTANCE TO IMPROVE ABNORMAL CARDIOVASCULAR CONTROL IN DIABETES$39,390
R01 · FY2021 · HL · contact PI
TARGETING INSULIN RESISTANCE TO IMPROVE ABNORMAL CARDIOVASCULAR CONTROL IN DIABETES$403,732
R01 · FY2020 · HL · contact PI